Depression of Monocyte Inflammatory Response with Pregnancy, Cancer, Regeneration and Surgical Wound Repair

  • S. Normann
  • J. Cornelius
  • M. Schardt
  • E. Sorkin
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 155)


Macrophage accumulation at inflammatory sites is depressed by tumor bearing (1,2) and this phenomenon may constitute a mechanism by which tumors abrogate host surveillance (3,4). However, is this anti-inflammatory effect unique to cancer? Could the tumor utilize an already established mechanism for regulating monocyte traffic and function? We speculate that the diversity of macrophage functions necessitates some form of biological control mechanism to prevent untoward reactions. The purpose of this communication is to explore this issue by examining anti-inflammation consequent to several noncancerous conditions as well as during growth of both spontaneous and transplanted tumors.


Macrophage Accumulation Macrophage Response Cancer Bear Animal Biological Control Mechanism Tactic Mobility 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Normann, S. J., and Sorkin, E., J. Natl. Cancer Institute 57:135, 1976.Google Scholar
  2. 2.
    Snyderman, R. M., Pike, M. C., Blaylock, B. L, and Weinstein, P., J. Immunology 116:585, 1976.Google Scholar
  3. 3.
    Pike, M. C., and Snyderman, R., J. Immunology 117:1243, 1976.Google Scholar
  4. 4.
    Adams, D. O., and Snyderman, R., J. Natl. Cancer Institute 62:1341, 1979.Google Scholar
  5. 5.
    Gill, R. J., and Repetti, C. F., Am. J. Pathology 95:465, 1979.Google Scholar
  6. 6.
    Persellin, R. H., Vance, S. E., and Peery, A., Br. J. Exp. Path. 55:25, 1974.Google Scholar
  7. 7.
    Normann, S. J., Schardt, M., Cornelius, J., and Sorkin, E., J. Reticuloendothelial Soc. 30:89, 1981.Google Scholar
  8. 8.
    Boers, W., van Gool, J., and Zwart, N. A., Br. J. Exp. Path. 60:239, 1979.Google Scholar
  9. 9.
    Normann, S. J., Schardt, M., and Sorkin E., J. Natl. Cancer Inst. 63:825, 1979.PubMedGoogle Scholar
  10. 10.
    Normann, S. J., Schardt, M., and Sorkin E., J. Natl. Cancer Inst. 66:157, 1981.PubMedGoogle Scholar
  11. 11.
    Normann, S. J., and Schardt, M., J. Reticuloendothelial Soc. 23:153, 1978.Google Scholar
  12. 12.
    Normann, S. J., Schardt, M., and Sorkin, Int. J. Cancer 23:110, 1979.PubMedCrossRefGoogle Scholar
  13. 13.
    Normann, S. J., Schardt, M., and Sorkin, E., Int. J. Cancer 28:185, 1981.PubMedCrossRefGoogle Scholar
  14. 14.
    Snyderman, R., Seigler, H. F., and Meadows, L., J. Natl. Cancer Inst. 58:37, 1977.PubMedGoogle Scholar
  15. 15.
    Snyderman, R., Meadows, L., Holder, W., and Wells, S., J. Natl. Cancer Inst. 60:737, 1978.PubMedGoogle Scholar
  16. 16.
    Normann, S. J., J. Natl. Cancer Inst. 60:1091, 1978.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1982

Authors and Affiliations

  • S. Normann
    • 1
  • J. Cornelius
    • 1
  • M. Schardt
    • 2
  • E. Sorkin
    • 2
  1. 1.Department of PathologyUniversity of FloridaGainesvilleUSA
  2. 2.Medizinische AbteilungSchweizerisches ForschungsinstitutDavosSwitzerland

Personalised recommendations